Cargando…

Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease

The aggregation of amyloid-β (Aβ) peptides into oligomers and fibrils is a key pathological feature of Alzheimer's disease (AD). An increasing amount of evidence suggests that oligomeric Aβ might be the major culprit responsible for various neuropathological changes in AD. Death-associated prot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tao, Xia, Yongfang, Hu, Li, Chen, Dongmei, Gan, Chen-Ling, Wang, Long, Mei, Yingxue, Lan, Guihua, Shui, Xindong, Tian, Yuan, Li, Ruomeng, Zhang, Mi, Lee, Tae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741852/ https://www.ncbi.nlm.nih.gov/pubmed/35002518 http://dx.doi.org/10.7150/ijbs.66760

Ejemplares similares

Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
por: Chen, Dongmei, et al.
Publicado: (2022)

miR-143-3p Inhibits Aberrant Tau Phosphorylation and Amyloidogenic Processing of APP by Directly Targeting DAPK1 in Alzheimer’s Disease
por: Wang, Long, et al.
Publicado: (2022)

Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice
por: Gan, Chen-Ling, et al.
Publicado: (2021)

Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy
por: Gan, Chen-Ling, et al.
Publicado: (2022)

Ablation of Death-Associated Protein Kinase 1 Changes the Transcriptomic Profile and Alters Neural-Related Pathways in the Brain
por: Li, Ruomeng, et al.
Publicado: (2023)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Detection of Alzheimer's disease amyloid beta 1‐42, p‐tau, and t‐tau assays
por: van Harten, Argonde C., et al.
Publicado: (2021)

Effects of Terahertz Radiation on the Aggregation of Alzheimer’s Aβ42 Peptide
por: Wang, Lei, et al.
Publicado: (2023)

Kinetics of tau aggregation reveals patient-specific tau characteristics among Alzheimer’s cases
por: Kamath, Tarun V, et al.
Publicado: (2021)

Nonphosphorylated tau slows down Aβ(1–42) aggregation, binds to Aβ(1–42) oligomers, and reduces Aβ(1–42) toxicity
por: Beeg, Marten, et al.
Publicado: (2021)

Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain
por: Podvin, Sonia, et al.
Publicado: (2022)

Relationship between cortical iron and tau aggregation in Alzheimer’s disease
por: Spotorno, Nicola, et al.
Publicado: (2020)

Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease
por: Dubey, Tushar, et al.
Publicado: (2019)

Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease
por: Jia, Longfei, et al.
Publicado: (2021)

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models
por: Zou, Yulian, et al.
Publicado: (2021)

The nonlinear relationship between cerebrospinal fluid Aβ(42) and tau in preclinical Alzheimer’s disease
por: de Leon, Mony J., et al.
Publicado: (2018)

In vitro generation of tau aggregates conformationally distinct from parent tau seeds of Alzheimer’s brain
por: Nam, Won-Hee, et al.
Publicado: (2018)

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts
por: Lue, Lih-Fen, et al.
Publicado: (2017)

Pathological Tau From Alzheimer’s Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
por: Miao, Jin, et al.
Publicado: (2019)

Pro-aggregant Tau impairs mossy fiber plasticity due to structural changes and Ca(++) dysregulation
por: Decker, Jochen Martin, et al.
Publicado: (2015)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease
por: Kraus, Allison, et al.
Publicado: (2018)

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
por: Sonawane, Shweta Kishor, et al.
Publicado: (2019)

Espresso Coffee Mitigates the Aggregation and Condensation of Alzheimer′s Associated Tau Protein
por: Tira, Roberto, et al.
Publicado: (2023)

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
por: Ashton, Nicholas J., et al.
Publicado: (2022)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
por: Henjum, Kristi, et al.
Publicado: (2018)

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases
por: Duka, Valeriy, et al.
Publicado: (2013)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation
por: Park, Jun Sung, et al.
Publicado: (2019)

Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation
por: Pahrudin Arrozi, Aslina, et al.
Publicado: (2021)

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
por: Pichet Binette, Alexa, et al.
Publicado: (2022)

PKR kinase directly regulates tau expression and Alzheimer's disease‐related tau phosphorylation
por: Reimer, Lasse, et al.
Publicado: (2020)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer’s disease
por: Ghosh, Preetam, et al.
Publicado: (2010)

Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid
por: Frankel, Rebecca, et al.
Publicado: (2019)

Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021)

Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
por: Harrington, Charles R., et al.
Publicado: (2015)

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease
por: Shanthi, Keerthanaa Balasubramanian, et al.
Publicado: (2015)

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β ((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop
por: Teunissen, Charlotte E., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e2b5ko5234i7snr1sevr8lsfcc